SARS-CoV-2 Type & FLU RT-PCR Detection Mix 1.5
- UID
- IMP/IVD/2020/001064_891acd8848ac86bed867316d1df8c55d_fc49635383a411602f69923e240822bf
- Device class
- Class C
- Brand name
- AltoStar®
- License holder
- Altona Diagnostics India Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- The FlexStar SARS-CoV-2 Type & FLU RT-PCR Detection Mix 1.5 is an in-vitro diagnostic test, based on real-time PCR technology, for the qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (AltoStar®) and influenza virus specific RNA in human respiratory swab specimens. The SARS-CoV-2 detection is based on the parallel detection of the E gene of lineage B- beta coronavirus (AltoStar®) and the S gene of SARS-CoV-2. The FlexStar SARS-CoV-2 Type & FLU RTPCR Detection Mix 1.5 is intended to be used as an aid of diagnosis of SARS-CoV-2 and influenza virus infection. The results generated with the FlexStar SARS-CoV-2 Type & FLU RT-PCR Detection Mix 1.5 have to be interpreted in conjunction with other clinical and laboratory findings. The FlexStar SARS-CoV-2 Type & FLU RT-PCR Detection Mix 1.5 is intended for use by professional users trained in molecular biological techniques and in vitro diagnostic procedures
SARS-CoV-2 Type & FLU RT-PCR Detection Mix 1.5 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001064_891acd8848ac86bed867316d1df8c55d_fc49635383a411602f69923e240822bf. This device is marketed under the brand name AltoStar®. The license holder is Altona Diagnostics India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.